<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Advaxis, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Advaxis, Inc.

    Advaxis was founded on the vision that no one should suffer from the burdens of cancer. Our goal is to develop cancer immunotherapies that teach the body to recognize tumors as a threat and do so in a way that minimizes side effects associated with traditional chemotherapy and radiation. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kenneth A. Berlin
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Chimerix, Inc.

    Chimerix, Inc.

    Chimerix is a development-stage biopharmaceutical company dedicated to acceleratin...

    Chimerix is a development-stage biopharmaceutic...

    Filing Type:    PU
    Immunic, Inc.

    Immunic, Inc.

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company develop...

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stag...

    Filing Type:    PU
    Genetic Technologies Ltd

    Genetic Technologies Ltd

    Genetic Technologies is a leader in the development of genetic technology. Our tes...

    Genetic Technologies is a leader in the develop...

    Filing Type:    PU
    Phenomix Sciences LLC

    Phenomix Sciences LLC

    The objective of Phenomix Sciences, LLC (Phenomix) is to provide healthcare soluti...

    The objective of Phenomix Sciences, LLC (Phenom...

    Amount Raised:    $288,547.00
    Fundraising Status:    EC
    Filing Type:    CF
    GEMSS North America, Inc.

    GEMSS North America, Inc.

    GEMSS North America is a leading developer, manufacturer & distributor of Digital ...

    GEMSS North America is a leading developer, man...

    Filing Type:    CF
    GLG Pharma, LLC

    GLG Pharma, LLC

    GLG Pharma is a medical research and pharamaceutical company that develops persona...

    GLG Pharma is a medical research and pharamaceu...

    Fundraising Status:    VT
    Filing Type:    CF
    Theravance Biopharma, Inc.

    Theravance Biopharma, Inc.

    Theravance Biopharma is a diversified biopharmaceutical company with the core purp...

    Theravance Biopharma is a diversified biopharma...

    Filing Type:    PU
    InflaRx N.V.

    InflaRx N.V.

    InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on ap...

    InflaRx (Nasdaq: IFRX) is a clinical-stage biop...

    Filing Type:    PU
    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a clinical‑stage biopharmaceutical c...

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a c...

    Filing Type:    PU
    BeiGene, Ltd.

    BeiGene, Ltd.

    BeiGene, Ltd. (“BeiGene”) is a commercial-stage biotechnology company focused ...

    BeiGene, Ltd. (“BeiGene”) is a commercial-s...

    Filing Type:    PU
    Rigel Pharmaceuticals, Inc.

    Rigel Pharmaceuticals, Inc.

    Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, d...

    Rigel Pharmaceuticals, Inc. is a biotechnology ...

    Filing Type:    PU
    Gritstone Oncology, Inc.

    Gritstone Oncology, Inc.

    Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight mu...

    Gritstone Oncology is developing tumor-specific...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.